Literature DB >> 20810996

Albuminuria and the risk of incident stroke and stroke types in older adults.

M I Aguilar1, E S O'Meara, S Seliger, W T Longstreth, R G Hart, P E Pergola, M G Shlipak, R Katz, M J Sarnak, D E Rifkin.   

Abstract

BACKGROUND: The kidney biomarker that best reflects risk of stroke is unknown. We sought to evaluate the association of stroke with 3 kidney biomarkers: albuminuria, cystatin C, and glomerular filtration rate.
METHODS: These 3 biomarkers were determined in 3,287 participants without history of stroke from the Cardiovascular Health Study, a longitudinal cohort study of men and women age 65 years and older from 4 US communities. The biomarkers were albuminuria ascertained using urinary albumin-to-creatinine ratio (UACR) from morning spot urine, creatinine-based estimated glomerular filtration rate (eGFR), and cystatin C. Outcomes were incident stroke (any, ischemic, or hemorrhagic) during follow-up between 1996 and 2006.
RESULTS: A total of 390 participants had an incident stroke: 81% ischemic, 12% hemorrhagic, and 7% unclassified. In adjusted Cox regression models, UACR was more strongly related to any stroke, ischemic stroke, and hemorrhagic stroke than eGFR and cystatin C. The hazard ratio (HR) of any stroke comparing the top to bottom quintile of UACR was 2.10 (95% confidence interval [CI] 1.47-3.00), while HR for eGFR was 1.29 (95% CI 0.91-1.84) and for cystatin C was 1.22 (95% CI 0.85-1.74). When considering clinically relevant categories, elevated UACR was associated with increased hazard of any stroke and ischemic stroke regardless of eGFR or cystatin C categories.
CONCLUSIONS: UACR was the kidney biomarker most strongly associated with risk of incident stroke. Results in this elderly cohort may not be applicable to younger populations. These findings suggest that measures of glomerular filtration and permeability have differential effects on stroke risk.

Entities:  

Mesh:

Year:  2010        PMID: 20810996      PMCID: PMC3013484          DOI: 10.1212/WNL.0b013e3181f73638

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Josef Coresh; Bonnie Macleod; Deeb N Salem; John L Griffith; Andrew S Levey; Mark J Sarnak
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

2.  Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.

Authors:  J S Jensen; B Feldt-Rasmussen; S Strandgaard; M Schroll; K Borch-Johnsen
Journal:  Hypertension       Date:  2000-04       Impact factor: 10.190

3.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

4.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.

Authors:  Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2008-12-12       Impact factor: 8.860

5.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

6.  Microalbuminuria in nondiabetic patients with acute ischemic stroke: prevalence, clinical correlates, and prognostic significance.

Authors:  Agnieszka Słowik; Wojciech Turaj; Tomasz Iskra; Jacek Strojny; Andrej Szczudlik
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

Review 7.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

8.  The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study.

Authors:  Joshua I Barzilay; Do Peterson; Mary Cushman; Susan R Heckbert; Jie J Cao; Caroline Blaum; Russell P Tracy; Ronald Klein; David M Herrington
Journal:  Am J Kidney Dis       Date:  2004-07       Impact factor: 8.860

9.  Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway.

Authors:  Solfrid Romundstad; Jostein Holmen; Kurt Kvenild; Hans Hallan; Hanne Ellekjaer
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860

10.  Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.

Authors:  Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Journal:  Ann Intern Med       Date:  2003-12-02       Impact factor: 25.391

View more
  24 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Relationship between kidney damage and stroke types in Japanese patients.

Authors:  Kosuke Kudo; Tsuneo Konta; Noriyuki Degawa; Shinjiro Saito; Rei Kondo; Takamasa Kayama; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2012-08       Impact factor: 2.801

3.  Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Authors:  D E Weiner; M A Carpenter; A S Levey; A Ivanova; E H Cole; L Hunsicker; B L Kasiske; S J Kim; J W Kusek; A G Bostom
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

4.  Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage.

Authors:  Mona Laible; Solveig Horstmann; Markus Möhlenbruch; Christian Wegele; Timolaos Rizos; Svenja Schüler; Markus Zorn; Roland Veltkamp
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

5.  Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.

Authors:  Manjula Kurella Tamura; Nicholas M Pajewski; R Nick Bryan; Daniel E Weiner; Matthew Diamond; Peter Van Buren; Addison Taylor; Srinivasan Beddhu; Clive Rosendorff; Hesamoddin Jahanian; Greg Zaharchuk
Journal:  Neurology       Date:  2016-02-26       Impact factor: 9.910

6.  Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke.

Authors:  Dongfang Xiao; Hailong Liu; Hong Zhang; Yumin Luo
Journal:  J Neurol       Date:  2012-02-18       Impact factor: 4.849

7.  Methodological evaluation and comparison of five urinary albumin measurements.

Authors:  Rui Liu; Gang Li; Xiao-Fan Cui; Dong-Ling Zhang; Qing-Hong Yang; Xiao-Yan Mu; Wen-Jie Pan
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

8.  Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study.

Authors:  Danielle K Sandsmark; Steven R Messé; Xiaoming Zhang; Jason Roy; Lisa Nessel; Lotuce Lee Hamm; Jiang He; Edward J Horwitz; Bernard G Jaar; Radhakrishna R Kallem; John W Kusek; Emile R Mohler; Anna Porter; Stephen L Seliger; Stephen M Sozio; Raymond R Townsend; Harold I Feldman; Scott E Kasner
Journal:  Stroke       Date:  2015-06-30       Impact factor: 7.914

9.  Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts.

Authors:  Bakhtawar K Mahmoodi; Hiroshi Yatsuya; Kunihiro Matsushita; Yinying Sang; Rebecca F Gottesman; Brad C Astor; Mark Woodward; W T Longstreth; Bruce M Psaty; Michael G Shlipak; Aaron R Folsom; Ron T Gansevoort; Josef Coresh
Journal:  Stroke       Date:  2014-05-29       Impact factor: 7.914

10.  Update in intracerebral hemorrhage.

Authors:  Maria I Aguilar; Thomas G Brott
Journal:  Neurohospitalist       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.